• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】16524

【品名】bromo(vinyl)magnesium

【CA登记号】1826-67-1

【 分 子 式 】C2H3BrMg

【 分 子 量 】131.25482

【元素组成】C 18.3% H 2.3% Br 60.88% Mg 18.52%

与该中间体有关的原料药合成路线共 33 条

合成路线1

该中间体在本合成路线中的序号:(B)

The reaction of 4-hydroxy-1-octyne (I), with chlorotrimethylsilane and imidazole in DMF gives 4-trimethylsilyloxy-1-octyne (II), which is converted into 1-iodo-4-trimethylsilyloxy-trans-1-octene (III) by reaction with bis(3-methyl-2-butyl)borane (A), trimethylamine oxide, NaOH and finally I2. The hydrolysis of (III) with acetic acid in THF affords 1-iodo-4-hydroxy-trans-1-octene (IV), which is oxidized with pyridinium chlorochromate in methylene chloride yielding 1-iodo-4-oxo-trans-1-octene (V). The Grignard reaction of (V) with vinylmagnesium bromide (B) in THF gives 4-hydroxy-4-vinyl-1-iodo-trans-1-octene (VI), which is protected with trimethylsilyl chloride as before yielding 4-trimethylsilyloxy-4-vinyl-1-iodo-trans-1-octene (VII). The reaction of (VII) with tert-butyllithium in ether and then with copper (1)-1-pentyne-tributylphosphine (C) in HMPT affords the copper salt (VIII), which is condensed with 2-(6-trimethylsilyloxycarbonyl-2-cis-hexenyl)-4-trimethylsilyloxycyclopent-2-en-1-one (IX) in ether - THF giving trimethylsilyl-9-oxo-11alpha,16-bistrimethylsilyloxy-16-vinyl-5-cis-13-trans-prostadienoate (X). The hydrolysis of (X) with acetic acid in THF-water yields 9-oxo-11alpha,16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoic acid (XI), which is finally methylated with diazomethane in ether.

1 Middlenton, B.F.; Martin, J.W.; Grudzinskas, C.V.; Chen, S.L. (American Cyanamid Co.); Novel prostaglandin compounds. ES 475787; FR 2410648; GB 2009173; US 4198521 .
2 Hillier, K.; Blancafort, P.; Serradell, M.N.; Castaner, J.; CL-115,347. Drugs Fut 1983, 8, 4, 307.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(A) 20452 bis(1,2-dimethylpropyl)borane 132509-17-2 C10H23B 详情 详情
(I) 29312 1-octyn-4-ol C8H14O 详情 详情
(II) 36018 [(1-butyl-3-butynyl)oxy](trimethyl)silane; 1-butyl-3-butynyl trimethylsilyl ether C11H22OSi 详情 详情
(III) 36019 (E)-1-butyl-4-iodo-3-butenyl trimethylsilyl ether; [[(E)-1-butyl-4-iodo-3-butenyl]oxy](trimethyl)silane C11H23IOSi 详情 详情
(IV) 29315 (E)-1-iodo-1-octen-4-ol C8H15IO 详情 详情
(V) 29316 (E)-1-iodo-1-octen-4-one C8H13IO 详情 详情
(VI) 29317 (5E)-3-butyl-6-iodo-1,5-hexadien-3-ol C10H17IO 详情 详情
(VII) 36020 (E)-1-butyl-4-iodo-1-vinyl-3-butenyl trimethylsilyl ether; [[(E)-1-butyl-4-iodo-1-vinyl-3-butenyl]oxy](trimethyl)silane C13H25IOSi 详情 详情
(VIII) 36021 [(1E)-4-butyl-4-[(trimethylsilyl)oxy]-1,5-hexadienyl](1-pentynyl)copper C18H32CuOSi 详情 详情
(IX) 36022 trimethylsilyl (Z)-7-[(3R)-5-oxo-3-[(trimethylsilyl)oxy]-1-cyclopenten-1-yl]-5-heptenoate C18H32O4Si2 详情 详情
(X) 36023 trimethylsilyl (Z)-7-[(1R,2R,3R)-2-[(1E)-4-butyl-4-[(trimethylsilyl)oxy]-1,5-hexadienyl]-5-oxo-3-[(trimethylsilyl)oxy]cyclopentyl]-5-heptenoate C31H58O5Si3 详情 详情
(XI) 36024 (Z)-7-[(1R,2R,3R)-2-[(1E)-4-butyl-4-hydroxy-1,5-hexadienyl]-3-hydroxy-5-oxocyclopentyl]-5-heptenoic acid C22H34O5 详情 详情
(C) 29069 1-pentynylcopper C5H7Cu 详情 详情

合成路线2

该中间体在本合成路线中的序号:(A)

The reaction of 4-hydroxy-1-octyne (I) with chlorotrimethylsilane and imidazole in DMF gives 4-trimethylsilyloxy-1-octyne (II), which is converted to 1-iodo-4-trimethylsilyloxy-trans-1-octene (III) by reaction with bis(3-methyl-2-butyl)borane, trimethylamine oxide, NaOH and finally I2. The hydrolysis of (III) with acetic acid in THF affords 1-iodo-4-hydroxy-trans-1-octene (IV), which is oxidized with pyridinium chlorochromate in methylene chloride yielding 1-iodo-4-oxo-trans-1-octene (V). The Grignard condensation of (V) with vinylmagnesium bromide in THF gives 4 hydroxy-4-vinyl-1-iodo-trans-1-octene (VI), which is protected with trimethylsilyl chloride as before yielding 4-trimethylsilyloxy-4-vinyl-1-iodo-trans-1-octene (VII). The reaction of (VII) with tert-butyllithium in ether and then with copper(I)-1-pentyne-tributylphosphine in HMPT affords the copper salt (VIII), which is condensed with 2-(6-trimethylsilyloxycarbonyl)-2-cis-hexenyl)-4-trimethylsilyloxycyclopent-2-en-1-one (IX) in ether-THF giving trimethylsilyl-9-oxo-11 alpha,16-bis(trimethylsilyloxy)-16-vinyl-5-cis-13-trans-prostadienoate (X). Finally, this compound is hydrolyzed with acetic acid in THF water.

1 Middlenton, B.F.; Martin, J.W.; Grudzinskas, C.V.; Chen, S.L. (American Cyanamid Co.); Novel prostaglandin compounds. ES 475787; FR 2410648; GB 2009173; US 4198521 .
2 Middlenton, B.F.; Martin, J.W.; Grudzinskas, C.V.; Chen, S.L. (American Cyanamid Co.); Nouveaux acides 15-désoxy-16-hydroprotanoïques 16-substitués doués d'activité pharmaceutiques et leur procédé de préparation. DE 2813342; ES 468353; FR 2385696; JP 7939047; US 4131737 .
3 Pfenning, J.; et al. (American Cyanamid Co.); 15-Deoxy-16-substituted protanoic acids. DE 2837530; ES 472908; FR 2401899; GB 2006186; JP 54046748; JP 7946748 .
4 Adaikan, P.G.; Serradell, M.N.; Castaner, J.; DHV-PGE2. Drugs Fut 1985, 10, 5, 382.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(B) 29319 1-Pentynyl copper salt tri(tert-butyl)phosphine complex C17H34CuP 详情 详情
(I) 29312 1-octyn-4-ol C8H14O 详情 详情
(II) 29313 (2-butyl-4-pentynyl)(trimethyl)silane C12H24Si 详情 详情
(III) 29314 [(E)-2-butyl-5-iodo-4-pentenyl](trimethyl)silane C12H25ISi 详情 详情
(IV) 29315 (E)-1-iodo-1-octen-4-ol C8H15IO 详情 详情
(V) 29316 (E)-1-iodo-1-octen-4-one C8H13IO 详情 详情
(VI) 29317 (5E)-3-butyl-6-iodo-1,5-hexadien-3-ol C10H17IO 详情 详情
(VII) 29318 [(E)-2-butyl-5-iodo-2-vinyl-4-pentenyl](trimethyl)silane C14H27ISi 详情 详情
(VIII) 29320 [(1E)-4-butyl-4-[(trimethylsilyl)methyl]-1,5-hexadienyl](1-pentynyl)copper C19H34CuSi 详情 详情
(IX) 29321 (4R)-2-[(Z)-7-oxo-8-(trimethylsilyl)-2-octenyl]-4-[(trimethylsilyl)methyl]-2-cyclopenten-1-one C20H36O2Si2 详情 详情
(X) 29322 (2R,3R,4R)-3-[(1E)-4-butyl-4-[(trimethylsilyl)methyl]-1,5-hexadienyl]-2-[(Z)-7-oxo-8-(trimethylsilyl)-2-octenyl]-4-[(trimethylsilyl)methyl]cyclopentanone C34H64O2Si3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XI)

The Diels-Alder cyclization of butadiene (VII) with 1,4-benzoquinone (VIII) in THF gives the naphthalenetrione (IX), which is acylated with acetic anhydride and TEA to yield the tetralone derivative (X). The Grignard reaction of (X) with vinylmagnesium bromide (XI) and CeCl3, followed by acylation with acetic anhydride, affords the tetraline derivative (XII), which is treated with NaBH4 and oxidized with cerium ammonium nitrate to provide the tetrahydronaphthoquinone (XIII). The cyclization of (XIII) with 4-acetoxy-3,4-dihydro-1H-2-benzopyran-1,3-dione (XIV) by means of NaH in THF gives the intermediate (XV), which rearranges to the tetracyclic dione (XVI). The palladium-catalyzed (PdCl2(MeCN)2) rearrangement of (XVI) in toluene yields the allyl acetate derivative (XVII), which is oxidized with peracetic acid and RuCl3 in water/acetonitrile/dichloromethane to afford the protected intermediate (XVIII). Finally, this compound is deprotected and simultaneously epimerized by a treatment with HCl in refluxing isopropanol/water to provide the desired target intermediate (II).

1 Hottop, T.; et al.; Synthesis of 4-demethoxyadriamycinone utilizing ruthenium-catalyzed oxidation of allyl acetates. Tetrahedron Lett 2001, 42, 19, 3343.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 50740 (7S,9S)-9-glycoloyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydro-5,12-naphthacenedione C20H16O8 详情 详情
(VII) 50730 [[(E)-3-(tert-butoxy)-1-methylene-2-propenyl]oxy](trimethyl)silane; (E)-3-(tert-butoxy)-1-methylene-2-propenyl trimethylsilyl ether C11H22O2Si 详情 详情
(VIII) 12633 Quinone; Benzo-1,4-quinone; 2,5-Cyclohexadiene-1,4-dione 106-51-4 C6H4O2 详情 详情
(IX) 50731 8-(tert-butoxy)-4a,7,8,8a-tetrahydro-1,4,6(5H)-naphthalenetrione C14H18O4 详情 详情
(X) 50732 4-(acetoxy)-5-(tert-butoxy)-7-oxo-5,6,7,8-tetrahydro-1-naphthalenyl acetate C18H22O6 详情 详情
(XI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XII) 50733 (2S,4S)-5,8-bis(acetoxy)-4-(tert-butoxy)-2-vinyl-1,2,3,4-tetrahydro-2-naphthalenyl acetate C22H28O7 详情 详情
(XIII) 50734 (2S,4S)-4-(tert-butoxy)-5,8-dioxo-2-vinyl-1,2,3,4,5,8-hexahydro-2-naphthalenyl acetate C18H22O5 详情 详情
(XIV) 50735 1,3-dioxo-3,4-dihydro-1H-isochromen-4-yl acetate C11H8O5 详情 详情
(XV) 50736 (2S,4S)-6-(acetoxy)-4-(tert-butoxy)-11-hydroxy-5,12-dioxo-2-vinyl-1,2,3,4,5,12-hexahydro-2-naphthacenyl acetate C28H28O8 详情 详情
(XVI) 50737 (2S,4S)-2-(acetoxy)-4-(tert-butoxy)-12-hydroxy-6,11-dioxo-2-vinyl-1,2,3,4,6,11-hexahydro-5-naphthacenyl acetate C28H28O8 详情 详情
(XVII) 50738 2-[5-(acetoxy)-4-(tert-butoxy)-12-hydroxy-6,11-dioxo-3,4,6,11-tetrahydro-2(1H)-naphthacenylidene]ethyl acetate C28H28O8 详情 详情
(XVIII) 50739 (2S,4R)-2-[2-(acetoxy)acetyl]-4-(tert-butoxy)-2,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-5-naphthacenyl acetate C28H28O10 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

Synthesis of intermediate 1,4-bis(3,4,5-trimethoxyphenyl)butane-1,4-dione (V). This compound can be obtained by three related methods: 1. The Grignard reaction of 3,4,5-trimethoxybenzaldehyde (I) with vinylmagnesium bromide (II), followed by oxidation with MnO2, gives 1-(3,4,5-trimethoxyphenyl)-2-propen-1-one (III), which is then condensed with aldehyde (I) by means of the thiazolium salt (IV) to yield the target intermediate (V). 2. The condensation of 3,4,5-trimethoxyacetophenone (VI) with methylamine and formaldehyde gives 3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-1-propanone (VII), which is treated with methyl iodide at 80 C to afford the previously reported propenone intermediate (III). 3.The direct dimerization of acetophenone (VI) by means of LDA and CuCl2 also gives the target intermediate (V). Synthesis of the target compound: The reduction of the butanedione intermediate (V) with LiAlH4 or NaBH4 gives (RS,RS)-1,4-bis(3,4,5-trimethoxyphenyl)butane-2,3-diol (IX), which is dehydrated to the target tetrahydrofuran by means of TFA, PdCl2/Cu(NO3)2 or MsCl/pyridine. Alternatively, the reduction of butanedione (V) can be performed stepwise, first with LiAlH(O-tBu)3 to give the intermediate hydroxyketone (VIII), which is reduced to the diol (IX). The isolation of the intermediate hydroxyketone (VIII) allows the separation of enantiomers offering the possibility of obtaining chiral forms of the target tetrahydrofuran.

1 Doebber, T.W.; Beattie, T.R.; Shen, T.-Y.; Hwang, S.-B.; Biftu, T. (Merck & Co., Inc.); New 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists. AU 8656430; EP 0199324; ES 8801909; JP 1987000077 .
2 Biftu, T.; Chabala, J.C.; Acton, J.; Kuo, C.-H.; Stevenson, R.; 2,5-DIARYLTETRAHYDROFURANS: PAF ANTAGONISTS. Drugs Fut 1989, 14, 4, 359.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11136 3,4,5-Trimethoxybenzaldehyde 86-81-7 C10H12O4 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 27941 1-(3,4,5-trimethoxyphenyl)-2-propen-1-one C12H14O4 详情 详情
(IV) 44365 3,4-diethyl-5-(2-hydroxyethyl)-1,3-thiazol-3-ium bromide C9H16BrNOS 详情 详情
(V) 44387 1,4-bis(3,4,5-trimethoxyphenyl)-1,4-butanedione C22H26O8 详情 详情
(VI) 44362 1-(3,4,5-trimethoxyphenyl)-1-ethanone 1136-86-3 C11H14O4 详情 详情
(VII) 44363 3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-1-propanone C14H21NO4 详情 详情
(VIII) 44388 4-hydroxy-1,4-bis(3,4,5-trimethoxyphenyl)-1-butanone C22H28O8 详情 详情
(IX) 44389 (1R,4R)-1,4-bis(3,4,5-trimethoxyphenyl)-1,4-butanediol C22H30O8 详情 详情

合成路线5

该中间体在本合成路线中的序号:(B)

The reaction of beta-ionon (X) with triethyl orthoformate (A) by means of H2SO4 in dioxane gives beta-ionon enolether (XI), which by reaction with NBS in CCl4 and hydrolysis with acetic acid is converted into 4-acetoxyonon (XII). The Grignard reaction of (XII) with vinylmagnesium bromide (B) in THF and hydrolysis with KOH in methanol gives 5-(3-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3-methylpenta-1,4-dien-3-ol (XIII), which is oxidized with MnO2 in methylene chloride yielding 5-(3-oxo-2,6,6-trimethylcyclohex-1-en-1-yl)-3-methylpenta-1,4-dien-3-ol (XIV). Finally, this compound by reaction with triphenylphosphonium bromide (C) in DMF is converted into the phosphonium salt (VIII), which is finally condensed in a Wittig reaction with 2,7-dimethyl-2,4,6-octatriene-1,8-dial (IX) by means of sodium methoxide in dichloromethane.

1 Rosenberg, M.; US 4000198 .
2 Serradell, M.N.; Blancafort, P.; Castaner, J.; Hillier, K.; Canthazanthin. Drugs Fut 1979, 4, 7, 477.
3 Rigassi, N.; Schwieter, U.; DE 2037935 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(A) 21304 Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether 122-51-0 C7H16O3 详情 详情
(VIII) 39582 [(2E,4E)-3-methyl-5-(2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienyl](triphenyl)phosphonium bromide C33H36BrOP 详情 详情
(IX) 39583 (2E,4E,6E)-2,7-dimethyl-2,4,6-octatrienedial C10H12O2 详情 详情
(X) 39584 (E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one 14901-07-6 C13H20O 详情 详情
(XI) 39585 6-[(Z,2Z)-3-methoxy-2-butenylidene]-1,5,5-trimethyl-1-cyclohexene; methyl (Z)-1-methyl-3-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-1-propenyl ether C14H22O 详情 详情
(XII) 39586 2,4,4-trimethyl-3-[(E)-3-oxo-1-butenyl]-2-cyclohexen-1-yl acetate C15H22O3 详情 详情
(XIII) 39587 3-[(1E)-3-hydroxy-3-methyl-1,4-pentadienyl]-2,4,4-trimethyl-2-cyclohexen-1-ol C15H24O2 详情 详情
(XIV) 39588 3-[(1E)-3-hydroxy-3-methyl-1,4-pentadienyl]-2,4,4-trimethyl-2-cyclohexen-1-one C15H22O2 详情 详情
(C) 39589 triphenylphosphonium bromide 6399-81-1 C18H16BrP 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

A new synthetic route to famciclovir has been described: The alkylation of 2,2-dimethyl-1,3-dioxan-5-one (I) with vinylmagnesium bromide (II) in THF gives the 2,2-dimethyl-5-vinyl-1,3-dioxan-5-ol derivative (II), which is treated with methyl chloroformate in the same solvent to yield the mixed carbonate (IV). Condensation of (IV) with 6-chloropurine-2-amine (V) by means of 1,2-bis(diphenylphosphino)ethane (dppe) and tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] in DMF at 80 °C for 7.5 h affords a 5:95 mixture of the N-7 (VI) and N-9 (VII) regioisomers, respectively. Hydrogenation of regioisomer (VII) with H2 over Pd/C in THF eliminates the 6-chlorine atom and reduces the exocyclic double bond giving the 2-aminopurine derivative (VIII), which is treated with HCl in methanol to remove the acetonide group affording diol (IX). Finally, this compound is acylated with acetic anhydride and DMAP/TEA in dichloromethane.

1 Geen, G.R.; Share, A.C.; Slater, G.R.; Ramsay, T.W.; Smith, N.M.; Freer, R.; A new route to famciclovir via palladium catalysed allylation. Tetrahedron 2000, 56, 26, 4589.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46538 2,2-dimethyl-1,3-dioxan-5-one C6H10O3 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 46539   C8H13BrMgO3 详情 详情
(IV) 46540 2,2-dimethyl-5-vinyl-1,3-dioxan-5-yl methyl carbonate C10H16O5 详情 详情
(V) 11644 6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine 10310-21-1 C5H4ClN5 详情 详情
(VI) 46541 6-chloro-7-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]-7H-purin-2-ylamine; 6-chloro-7-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]-7H-purin-2-amine C13H16ClN5O2 详情 详情
(VII) 46542 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]-9H-purin-2-ylamine; 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]-9H-purin-2-amine C13H16ClN5O2 详情 详情
(VIII) 46543 9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine; 9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-ylamine C13H19N5O2 详情 详情
(IX) 11643 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol C10H15N5O2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(B)

The 1alpha,3beta-diol (Ia) derived from ergosterol was used as the starting material. The alcohol (Ia) was converted to methoxymethyl derivative (Ib) by reaction with chloromethyl methyl ether (4 eq) in dichloromethane for 16 h, which was oxidized with 3 eq of N-methylmorpholine N-oxide in the presence of osmium tetroxide (0.5 eq) in tert-butanol:tetrahydrofuran:water (10:3:1) for 4 h at room temperature to afford the 22,23-diol. The resulting diol was then cleaved by sodium metaperiodate (2.5 eq) in aqueous tetrahydrofuran (5 h, room temperature) to give the 22-aldehyde (IIa) in 30% yield from (Ia). Reaction of (IIa) with 6 eq of vinyl magnesium bromide (tetrahydrofuran, 0 C to room temperature, 2 h) gave the allyl alcohol (IIb) as a mixture of C-22 diastereoisomers. The Claisen reaction of (IIb) with 10 eq of triethyl orthopropionate and a catalytic amount of propionic acid (benzene reflux, 16 h) gave gamma,delta-unsaturated ester (IIa) in 70% yield from (IIa). The lithium enolate of (IIIa) generated by lithium N-isopropylcyclohexylamide in tetrahydrofuran at -78 C was reacted with oxygen for 1 h and subsequent reduction with triethyl phosphine at -78 C gave the 25-hydroxy ester (IIIb) in 87% yield. (IIIb) was shown to be a 1:1 mixture of C-25 diastereoisomers by high-pressure liquid chromatographic (HPLC) analysis. Alkaline hydrolysis (KOH, methanol, 60 C, 2.5 h) of the ester gave the hydroxy acid (IIIc) in 87% yield. (IIIc) was treated with 6 eq of I2 in dichloromethane in the presence of pyridine (15 eq) to give the iodolactone (IVa) in 74% yield, which was separated into isomers by silica gel column chromatography in a 1.5:1 ratio.

1 Morris, D.S.; Norris, A.F.; Williams, D.H.; Structure and synthesis of 25-hydroxycholecalciferol-26,23-lactone, a metabolite of vitamin D3. J Org Chem 1981, 46, 3422-28.
2 Seino, Y.; Ishizuka, S.; 23(S),25(R)-1alpha,25-(OH)2-D3-26,23-Lactone. Drugs Fut 1992, 17, 8, 655.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(D) 20178 propionic acid 79-09-4 C3H6O2 详情 详情
(Ia) 31263 (1S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-1,3-diol C28H46O2 详情 详情
(A) 31264 4-methylmorpholin-4-ium-4-olate C5H11NO2 详情 详情
(Ib) 31265 (1S,8S,9S,10R,13R,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-17-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene; (1S,8S,9S,10R,13R,14S,17R)-1-(methoxymethoxy)-10,13-dimethyl-17-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl methoxymethyl ether C32H54O4 详情 详情
(IIa) 31266 (2S)-2-[(1S,8S,9S,10R,13S,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanal C26H42O5 详情 详情
(IIb) 31267 (4S)-4-[(1S,8S,9S,10R,13S,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-penten-3-ol C28H46O5 详情 详情
(E) 31268 N-Cyclohexyl-N-methylamide lithium salt C9H18LiN 详情 详情
(IIIa) 31269 ethyl (E,6R)-6-[(1S,8S,9S,10R,13R,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-heptenoate C33H54O6 详情 详情
(IIIb) 31270 ethyl (E,6R)-6-[(1S,8S,9S,10R,13R,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methyl-4-heptenoate C33H54O7 详情 详情
(IIIc) 31271 (E,6R)-6-[(1S,8S,9S,10R,13R,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methyl-4-heptenoic acid C31H50O7 详情 详情
(IVa) 31272 5-[(2S)-2-[(1S,8S,9S,10R,13S,14S,17R)-1,3-bis(methoxymethoxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-iodopropyl]-3-hydroxy-3-methyldihydro-2(3H)-furanone C31H49IO7 详情 详情
(C) 10395 1,1,1-Triethoxypropane; 1,1-Diethoxypropyl ethyl ether; Triethyl orthopropionate 115-80-0 C9H20O3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(XXI)

Compound (XIII) can follow two different routes for its conversion into the intermediate product (XXIV): i) Reaction of (XIII) with vinylmagnesium bromide (XXI) in THF provides vinyl derivative (XXII), which is then converted into aldehyde (XXIII) by ozonolysis, followed by addition of dimethylsulfide (DMS). Reduction of aldehyde (XXIII) by means of NaBH4 in MeOH affords alcohol (XXIV). Conversion of (XXII) into (XXIV) can also be achieved by first treatment with NaIO4 and OsO4 in MeOH/H2O followed by reduction with NaBH4 in MeOH. ii) Treatment of (XIII) with (dimethylisopropoxysilyl)-methylmagnesium chloride (XXVII) in THF provides derivative (XXVIII), which is then converted into (XXIV) by treatment with H2O2/NaHCO3 in MeOH-THF. Final conversion of (XXIV) into the target product is achieved by first mesylation of (XXIV) by means of MsCl and Et3N in EtOAc to yield mesylated derivative (XXV), followed by its reaction with 1H-1,2,4-triazole in DMF in the presence of K2CO3.

1 Kitazaki, T.; et al.; Optically active antifungal azoles. IX. An alternative synthetic route for 2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-3(2H,4H)-1,2,4-triazolone and its analogs. Chem Pharm Bull 1999, 47, 3, 360.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIII) 43507 2-[(1R)-2-(2,4-difluorophenyl)-1-methyl-2-oxoethyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C20H15F6N3O3 详情 详情
(XXI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XXII) 43513 2-[(1R,2S)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-butenyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C22H19F6N3O3 详情 详情
(XXIII) 43515 (2S,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[5-oxo-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl]butanal C21H17F6N3O4 详情 详情
(XXIV) 43516 2-[(1R,2S)-2-(2,4-difluorophenyl)-2,3-dihydroxy-1-methylpropyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C21H19F6N3O4 详情 详情
(XXV) 43517 2-((1R,2S)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]propyl)-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C24H25F6N3O4S 详情 详情
(XXVI) 13135 1H-1,2,4-Triazole; 1,2,4-Triazole 288-88-0 C2H3N3 详情 详情
(XXVII) 43512 chloro[[isopropoxy(dimethyl)silyl]methyl]magnesium C6H15ClMgOSi 详情 详情
(XXVIII) 43514 2-[(1R,2S)-2-(2,4-difluorophenyl)-2-hydroxy-3-[isopropoxy(dimethyl)silyl]-1-methylpropyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C26H31F6N3O4Si 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

Montelukast can be obtained by two related ways: 1) The Grignard reaction of 3-[2(E)-(7-chloroquinolin-2-yl)vinyl]benzaldehyde (I) with vinylmagnesium bromide (II) in toluene/THF gives the expected secondary alcohol (III), which is condensed with methyl 2-bromobenzoate (IV) by means of palladium acetate and lithium acetate in DMF to yield methyl 2-[3-[3-[2(E)-(7-chloroquinolin-2-yl)vinyl]phenyl]-3-oxopropyl]benzoate (V). The enantioselective reduction of the keto group of (V) with (-)-B-chlorodiisopinocampheylborane in THF affords methyl 2-[3-[3-[2(E)-(7-chloroquinolin-2-yl)vinyl]phenyl]-3(S)-hydroxypropyl] benzoate (VI), which is reacted with methylmagnesium bromide in toluene/THF or methylmagnesium chloride/CeCl3 in THF to give the expected tertiary diol (VII). The selective esterification of (VII) with mesyl chloride and diisopropylethylamine in toluene/acetonitrile yields the expected secondary mesylate (VIII), which is condensed with 2-[1-(sulfanylmethyl)cyclopropyl]acetic acid (IX) by means of butyllithium in THF to afford the corresponding condensation product as free acid that is separated by addition of dicyclohexylamine and precipitates the corresponding salt (X). Finally, this dicyclohexylamine salt (X) is treated with NaOH in toluene/water. 2) The 2-[1-(sulfanylmethyl)cyclopropyl]acetic acid (IX) has been obtained as follows: The reaction of 1,1-cyclopropanedimethanol (XI) with SOCl2 or diisopropyl sulfite in dichloromethane gives 1,1-cyclopropanedimethanol cyclic sulfite (XII), which is treated with NaCN in dichloromethane yielding 2-[1-(hydroxymethyl)cyclopropyl]acetonitrile (XIII). The reaction of (XIII) with mesyl chloride and triethylamine affords the corresponding mesylate (XIV), which is treated with potassium thioacetate in isopropyl acetate giving 2-[1-(acetylsulfanyl)cyclopropyl]acetonitrile (XV). Finally, this compound is hydrolyzed with NaOH in toluene/water to afford (IX).

1 Graul, A.; Martín, L.; Castañer, J.; Montelukast Sodium. Drugs Fut 1997, 22, 10, 1103.
2 Belley, M.L.; Leger, S.; Roy, P.; Xiang, Y.B.; Labelle, M.; Guay, D. (Merck Frosst Canada Inc.); Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists. EP 0480717; JP 1993105665 .
3 Bhupathy, M.; McNamara, J.M.; Sidler, D.R.; Volante, R.P.; Bergan, J.J. (Merck & Co., Inc.); Process for the preparation of leukotriene antagonists. WO 9518107 .
4 King, S.; Pipik, B.; Conlon, D.A. (Merck & Co., Inc.); Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid. US 5523477 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
27347 N,N-dicyclohexylamine 101-83-7 C12H23N 详情 详情
(I) 16523 3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]benzaldehyde C18H12ClNO 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 16525 1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-2-propen-1-ol C20H16ClNO 详情 详情
(IV) 15938 methyl 2-bromobenzoate 610-94-6 C8H7BrO2 详情 详情
(V) 16527 methyl 2-(3-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl)benzoate C28H22ClNO3 详情 详情
(VI) 16528 methyl 2-((3S)-3-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl)benzoate C28H24ClNO3 详情 详情
(VII) 16529 (1S)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanol C29H28ClNO2 详情 详情
(VIII) 16530 (1S)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl methanesulfonate C30H30ClNO4S 详情 详情
(IX) 16531 2-[1-(sulfanylmethyl)cyclopropyl]acetic acid; 1-(mercaptomethyl)cyclopropane acetic acid C6H10O2S 详情 详情
(X) 16532 2-[1-[1(R)-[3-[2(E)-(7-Chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propylsulfanylmethyl]cyclopropyl]acetic acid dicyclohexylamine salt C47H59ClN2O3S 详情 详情
(XI) 16533 [1-(hydroxymethyl)cyclopropyl]methanol C5H10O2 详情 详情
(XII) 16534 5,7-dioxa-6lambda(4)-thiaspiro[2.5]octan-6-one C5H8O3S 详情 详情
(XIII) 16535 2-[1-(hydroxymethyl)cyclopropyl]acetonitrile C6H9NO 详情 详情
(XIV) 16536 [1-(cyanomethyl)cyclopropyl]methyl methanesulfonate C7H11NO3S 详情 详情
(XV) 16537 S-[[1-(cyanomethyl)cyclopropyl]methyl] ethanethioate C8H11NOS 详情 详情

合成路线10

该中间体在本合成路线中的序号:(IV)

A new synthesis of FTY-720 has been reported: Condensation of 4-chlorobenzaldehyde (I) with octylzinc iodide (II) by means of Ni(0) gives 4-octylbenzaldehyde (III), which is treated with vinylmagnesium bromide (IV) to yield the allyl alcohol (V). Epoxidation of (V) with MCPBA affords the epoxide (VI), which is opened by means of NaNO2 and MgSO4 in refluxing methanol to provide 3-nitro-1-(4-octylphenyl)propane-1,2-diol (VII). Reaction of diol (VII) with trimethylsilyl chloride and NaI in acetonitrile gives 3-nitro-1-(4-octylphenyl)-1-propene (VIII), which is hydrogenated with H2 over Pd/C in ethanol yielding the corresponding nitropropane derivative (IX). The bis-formylation of compound (IX) with aqueous HCHO in the presence of Amberlyst A-21 in dichloromethane affords 2-nitro-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (X), which is finally reduced with H2 over Ra-Ni to provide FTY-720.

1 Kalita, B.; Barua, N.C.; Bez, G; Bezbarua, M.; Synthesis of 2-nitro alcohols by regioselective ring opening of epoxides with MgSO4/NeOH/NaNO2 system: A short synthesis of immunosuppressive agent FTY-720. Synlett 2001, 9, 1411.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(II) 53249 iodo(octyl)zinc n/a C8H17IZn 详情 详情
(III) 53250 4-Octylbenzaldehyde 49763-66-8 C15H22O 详情 详情
(IV) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(V) 53251 1-(4-octylphenyl)-2-propen-1-ol n/a C17H26O 详情 详情
(VI) 53252 (4-octylphenyl)(2-oxiranyl)methanol n/a C17H26O2 详情 详情
(VII) 53253 3-nitro-1-(4-octylphenyl)-1,2-propanediol n/a C17H27NO4 详情 详情
(VIII) 53254 1-[(E)-3-nitro-1-propenyl]-4-octylbenzene n/a C17H25NO2 详情 详情
(IX) 53255 1-(3-nitropropyl)-4-octylbenzene n/a C17H27NO2 详情 详情
(X) 53256 2-nitro-2-(4-octylphenethyl)-1,3-propanediol n/a C19H31NO4 详情 详情

合成路线11

该中间体在本合成路线中的序号:(VI)

The esterification of L-phenylglycine (I) with AcCl and methanol gives the methyl ester (II), which is N-protected by means of Boc2O and TEA to yield the N-Boc derivative (III). The reduction of (III) with NaBH4 in ethanol/THF affords the alcohol (IV), which is oxidized by means of (COCl)2 and DMSO to provide the carbaldehyde (V). The reaction of (V) with vinylmagnesium bromide (VI) in THF gives the allyl alcohol (VII), which is protected with Tbdms-Cl and imidazole to yield the silyl ether (VIII). The alkylation of (VIII) with allyl bromide (IX) and NaH in DMF affords the N-allyl derivative (X), which is desilylated by means of TBAF and AcOH in THF to provide the allyl alcohol (XI). The ring closing metathesis reaction of (XI) with a Grubbs' catalyst in dichloromethane gives the tetrahydropyridine (XII), which is treated with H2 over Pd/C in ethanol to yield the chiral protected piperidine (XIII). The condensation of (XIII) with 3,5-bis(trifluoromethyl)benzyl bromide (XIV) by means of NaH in DMF affords the benzyl ether (XV), which is finally deprotected with TFA to provide the target piperidine.

1 Bhaskar, G.; Rao, B.V.; Stereoselective synthesis of L-733,060. Tetrahedron Lett 2003, 44, 5, 915.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10716 (2S)-2-Amino-2-phenylethanoic acid; L-(+)-alpha-Phenylglycine 2935-35-5 C8H9NO2 详情 详情
(II) 10717 methyl (2S)-2-amino-2-phenylethanoate C9H11NO2 详情 详情
(III) 12485 methyl (2S)-2-[(tert-butoxycarbonyl)amino]-2-phenylethanoate C14H19NO4 详情 详情
(IV) 59225 (R)-N-(tert-Butoxycarbonyl)-phenylglycinol; N-t-BOC-D-phenylglycinol 102089-74-7 C13H19NO3 详情 详情
(V) 45428 tert-butyl (1S)-2-oxo-1-phenylethylcarbamate C13H17NO3 详情 详情
(VI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(VII) 64501 tert-butyl (1S,2S)-2-hydroxy-1-phenyl-3-butenylcarbamate C15H21NO3 详情 详情
(VIII) 64502 tert-butyl (1S,2S)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-phenyl-3-butenylcarbamate C21H35NO3Si 详情 详情
(IX) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(X) 64503 tert-butyl allyl((1S,2S)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-phenyl-3-butenyl)carbamate C24H39NO3Si 详情 详情
(XI) 64504 tert-butyl allyl[(1S,2S)-2-hydroxy-1-phenyl-3-butenyl]carbamate C18H25NO3 详情 详情
(XII) 64505 tert-butyl (2S,3S)-3-hydroxy-2-phenyl-3,6-dihydro-1(2H)-pyridinecarboxylate C16H21NO3 详情 详情
(XIII) 64499 tert-butyl (2S,3S)-3-hydroxy-2-phenyl-1-piperidinecarboxylate C16H23NO3 详情 详情
(XIV) 27677 1-(bromomethyl)-3,5-bis(trifluoromethyl)benzene 32247-96-4 C9H5BrF6 详情 详情
(XV) 64500 tert-butyl (2S,3S)-3-{[3,5-bis(trifluoromethyl)benzyl]oxy}-2-phenyl-1-piperidinecarboxylate C25H27F6NO3 详情 详情

合成路线12

该中间体在本合成路线中的序号:(XVIII)

Synthesis of the thiazole intermediate (XXVI): The Grignard reaction of 2-methyl-3-(2-methylthiazol-4-yl)-2(E)-propenal (XVII) with vinylmagnesium bromide (XVIII) in THF gives the racemic secondary alcohol (XIX), which is submitted to enzymatic optical resolution with Pseudomonas AK lipase and vinyl acetate to yield the desired (S)-secondary alcohol (XX) along with the (R)-acetate, which is easily separated by chromatography. The silylation of (XX) with Tbdms-Cl and imidazole in DMF affords the silyl ether (XXI). The selective hydroboration of the terminal double bond of (XXI) with dicyclohexylborane followed by oxidation with H2O2 provided the primary alcohol (XXII), which is oxidized with DMP in dichloromethane to give the corresponding aldehyde (XXIII). The reaction of (XXIII) with the iodomethyl phosphonium salt (XXIV) by means of NaHMDS in THF yields the cis-iodovinyl compound (XXV), which is desilylated with aqueous HF in acetonitrile, affording the corresponding alcohol (XXVI). Finally, this alcohol is treated with acetic anhydride, TEA and DMAP to provide the desired thiazole intermediate (XXVII).

1 Panek, J.S.; Zhu, B.; Total synthesis of apothilone A. Org Lett 2000, 2, 17, 2575.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVII) 44456 (E)-2-methyl-3-(2-methyl-1,3-thiazol-4-yl)-2-propenal C8H9NOS 详情 详情
(XVIII) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XIX) 44488 (1E)-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,4-pentadien-3-ol C10H13NOS 详情 详情
(XX) 44489 (1E,3S)-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,4-pentadien-3-ol C10H13NOS 详情 详情
(XXI) 44490 tert-butyl(dimethyl)silyl (1S,2E)-2-methyl-3-(2-methyl-1,3-thiazol-4-yl)-1-vinyl-2-propenyl ether; 4-((1E,3S)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-methyl-1,4-pentadienyl)-2-methyl-1,3-thiazole C16H27NOSSi 详情 详情
(XXII) 40821 (3S,4E)-3-[[tert-butyl(dimethyl)silyl]oxy]-4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-4-penten-1-ol C16H29NO2SSi 详情 详情
(XXIII) 40822 (3S,4E)-3-[[tert-butyl(dimethyl)silyl]oxy]-4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-4-pentenal C16H27NO2SSi 详情 详情
(XXIV) 42718 (iodomethyl)(triphenyl)phosphonium iodide n/a C19H17I2P 详情 详情
(XXV) 44491 4-((1E,3S,5Z)-3-[[tert-butyl(dimethyl)silyl]oxy]-6-iodo-2-methyl-1,5-hexadienyl)-2-methyl-1,3-thiazole; tert-butyl(dimethyl)silyl (1S,3Z)-4-iodo-1-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-3-butenyl ether C17H28INOSSi 详情 详情
(XXVI) 44492 (1E,3S,5Z)-6-iodo-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,5-hexadien-3-ol C11H14INOS 详情 详情
(XXVII) 44493 (1S,3Z)-4-iodo-1-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-3-butenyl acetate C13H16INO2S 详情 详情

合成路线13

该中间体在本合成路线中的序号:(V)

Treatment of (R)-1-chloro-2,3-propanediol (I) with either K2CO3 or Cs2CO3 in CH2Cl2, followed by O-protection with Trt-Cl and Et3N in CH2Cl2, yields (S)-trityl glycidol (II). Alternatively, derivative (II) can also be obtained either by direct O-protection of (R)-glycidol (III) by means of Trt-Cl and Et3N in refluxing CH2Cl2 or by cyclization of protected propanediol derivative (IV)--obtained from treatment of compound (I) with Trt-Cl and Et3N in CH2Cl2--by means of KOH in EtOH. Reaction of (S)-trityl glycidol (II) with vinyl magnesium bromide (V) by means of CuI in THF provides (S)-1-(triphenylmethoxy)-4-penten-2-ol (VI), which is then condensed with allyl bromide (VII) with KOtBu or NaH in THF to afford compound (VIII). Ozonolysis of (VIII) in CH2Cl2/MeOH, followed by reductive quench with NaBH4 in NaOH, gives (S)-3-(2-hydroxyethoxy)-4-(triphenylmethoxy)-1-butanol (IX), which is then treated with MsCl/Et3N in CH2Cl2 to yield bismesylate (X). Coupling of compound (X) with 2,3-bis(1H-indol-3-yl)-N-methylmaleimide (XI) [obtained by treatment of dichloromaleic anhydride (XII) with methylamine hydrochloride by means of NaOMe in HOAc to furnish dichloro-N-methylmaleimide (XIII), followed by Grignard reaction of (XIII) with indole (XIV) in toluene/THF by means of EtMgBr in Et2O] by means of Cs2CO3 in DMF gives the 14-membered macrocycle (XV).

1 Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
2 Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
3 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
4 Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
5 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49696 (S)-(+)-Alpha-Chlorohydrin; (S)-(+)-3-Chloro-1,2-propanediol; (S)-3-Chloro-1,2-propanediol 60827-45-4 C3H7ClO2 详情 详情
(II) 41006 (2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane C22H20O2 详情 详情
(III) 19241 (2S)oxiranylmethanol 60456-23-7 C3H6O2 详情 详情
(IV) 51942 (2R)-1-chloro-3-(trityloxy)-2-propanol C22H21ClO2 详情 详情
(V) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(VI) 41007 (2S)-1-(trityloxy)-4-penten-2-ol C24H24O2 详情 详情
(VII) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(VIII) 41008 1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether C27H28O2 详情 详情
(IX) 41010 (3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol C25H28O4 详情 详情
(X) 51943 (7S)-2,11-dimethyl-2,11-dimethylene-7-[(trityloxy)methyl]-3,6,10-trioxa-2lambda(6),11lambda(6)-dithia-1,11-dodecadiene; 2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]ethyl (1S)-3-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]-1-[(trityloxy)methyl]propyl ether C31H40O4S2 详情 详情
(XI) 51012 5-(tert-butyl) 1-(2,3,5,6-tetrafluorophenyl) (2S)-2-[[(2S)-2-[[(benzyloxy)carbonyl]amino]-5-(tert-butoxy)-5-oxopentanoyl]amino]pentanedioate C32H38F4N2O9 详情 详情
(XII) 21947 3,4-dichloro-2,5-furandione 1122-17-4 C4Cl2O3 详情 详情
(XIII) 41029 3,4-dichloro-1-methyl-1H-pyrrole-2,5-dione C5H3Cl2NO2 详情 详情
(XIV) 15292 Indole; 1H-indole 120-72-9 C8H7N 详情 详情
(XV) 41016 (18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C46H39N3O4 详情 详情

合成路线14

该中间体在本合成路线中的序号:

The reaction of 1,6:2,3-dianhydro-4-O-benzyl-beta-D-mannopyranose (I) with vinylmagnesium bromide in THF gives 1,6-anhydro-4-O-benzyl-2-deoxy-2-C-vinyl-beta-D-glucopyranose (II), which is treated with O3 and NaBH4 in EtOH/H2O yielding 1,6-anhydro-4-O-benzyl-2-deoxy-2-C-(hydroxymethyl)-beta-D-glucopyranose (III). The hydrolysis of (III) with aqueous refluxing H2SO4 affords 4-O-benzyl-2-deoxy-2-C-(hydroxymethyl)-D-glucopyranose (IV), which is oxidized with NaIO4 in MeOH giving 4-O-benzyl-2-deoxy-2-C-(hydroxymethyl)-D-xylo-pentodialdose (V). The reductocyclization of (V) with ammonia and H2 over Pd/C provides the benzylated target compound (VI), which is finally deprotected with H2 over Pd/C in EtOH/HCl furnishing the target compound as a single (R,R,R) enantiomer.

1 Lundgren, K.; Kirk, O. (Novo Nordisk A/S); Piperidines and pyrrolidines. EP 0749423; JP 1997509947; WO 9524391 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(I) 38658 (1R,2S,4R,5S,6R)-5-(benzyloxy)-3,8,9-trioxatricyclo[4.2.1.0(2,4)]nonane; benzyl (1R,2S,4R,5S,6R)-3,8,9-trioxatricyclo[4.2.1.0(2,4)]non-5-yl ether 33208-47-8 C13H14O4 详情 详情
(II) 38659 (1R,2S,3R,4R,5R)-2-(benzyloxy)-4-vinyl-6,8-dioxabicyclo[3.2.1]octan-3-ol C15H18O4 详情 详情
(III) 38660 (1R,2S,3R,4R,5R)-2-(benzyloxy)-4-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol C14H18O5 详情 详情
(IV) 38661 (3R,4R,5S,6R)-5-(benzyloxy)-3,6-bis(hydroxymethyl)tetrahydro-2H-pyran-2,4-diol C14H20O6 详情 详情
(V) 38662 (2S,3R,4R)-2-(benzyloxy)-3-hydroxy-4-(hydroxymethyl)pentanedial C13H16O5 详情 详情
(VI) 38663 (3R,4R,5R)-3-(benzyloxy)-5-(hydroxymethyl)-4-piperidinol C13H19NO3 详情 详情

合成路线15

该中间体在本合成路线中的序号:

The reaction of oxirane (I) with vinylmagnesium bromide in THF gives 1-(4-fluorophenoxy)-4-penten-2(S)-ol (II), which is treated with ethyl vinyl ether and mercuric trifluoroacetate to yield the vinyl ether (III). The cyclization of (III) by means of Grubb's catalyst in refluxing benzene affords the dihydrofuran (IV), which is treated with benzenesulfinic acid in dichloromethane to give the sulfone (V). The reaction of (V) with the acetylenic tetrahydropyranyl ether (VI) by means of isopropylmagnesium bromide in THF yields the expected addition product (VII), which is treated with TsOH to eliminate the tetrahydropyranyl group and provide the alcohol (VIII). The condensation of (VIII) with N,O-bis (phenoxycarbonyl)hydroxylamine (IX) by means of PPh3 and DEAD in THF affords the protected carbamate derivative (X), which is finally treated with ammonia in methanol.

1 Gurjar, M.K.; et al.; A versatile approach to anti-asthmatic compound CMI-977 and its six-membered analogue. Synthesis 2000, 4, 557.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
18762 1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene 109-92-2 C4H8O 详情 详情
40726 dioxo(phenyl)-lambda(6)-sulfane C6H6O2S 详情 详情
(I) 32986 4-fluorophenyl (2S)oxiranylmethyl ether; (2S)-2-[(4-fluorophenoxy)methyl]oxirane 108648-25-5 C9H9FO2 详情 详情
(II) 38536 (2S)-1-(4-fluorophenoxy)-4-penten-2-ol C11H13FO2 详情 详情
(III) 38537 (1S)-1-[(4-fluorophenoxy)methyl]-3-butenyl vinyl ether; 1-fluoro-4-[[(2S)-2-(vinyloxy)-4-pentenyl]oxy]benzene C13H15FO2 详情 详情
(IV) 38538 (2S)-2-[(4-fluorophenoxy)methyl]-2,3-dihydrofuran; (2S)-2,3-dihydro-2-furanylmethyl 4-fluorophenyl ether C11H11FO2 详情 详情
(V) 38539 (2S,5R)-2-[(4-fluorophenoxy)methyl]-5-(phenylsulfonyl)tetrahydrofuran; (2R,5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl phenyl sulfone C17H17FO4S 详情 详情
(VI) 38540 2-(4-pentynyloxy)tetrahydro-2H-pyran; 4-pentynyl tetrahydro-2H-pyran-2-yl ether 62992-46-5 C10H16O2 详情 详情
(VII) 38541 5-[(2S,5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-4-pentynyl tetrahydro-2H-pyran-2-yl ether; 2-[(5-[(2S,5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-4-pentynyl)oxy]tetrahydro-2H-pyran C21H27FO4 详情 详情
(VIII) 19645 4-[(2S,5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-3-butyn-1-ol C15H17FO3 详情 详情
(IX) 19646 1-[([[(phenoxycarbonyl)oxy]amino]carbonyl)oxy]benzene C14H11NO5 详情 详情
(X) 19647 (2S,5S)-2-[(4-fluorophenoxy)methyl]-5-(4-[(phenoxycarbonyl)[(phenoxycarbonyl)oxy]amino]-1-butynyl)tetrahydrofuran C29H26FNO7 详情 详情

合成路线16

该中间体在本合成路线中的序号:

Fischer esterification of 2,2,5,5-tetramethylhexanedioic acid (I) provided diethyl ester (II), which was subjected to acyloin condensation with sodium in xylene to furnish the alpha-hydroxy cyclohexanone (III). Further oxidation of (III) with CrO3 gave diketone (IV). This was condensed with 2,3-diaminopropionic acid (V) to afford, after esterification with MeOH and H2SO4, the quinoxaline ester (VI). Reduction of (VI) to alcohol (VII) employing diisobutylaluminum hydride, followed by Swern oxidation gave rise to aldehyde (VIII). Optionally, addition of vinylmagnesium bromide to (VIII), and further Swern oxidation of the allylic alcohol (IX) provided the alpha,beta-unsaturated ketone (X). Conversion to the required diketo precursor (XII) was achieved by two related strategies. Coupling of ethyl 4-formylbenzoate (XI) with the unsaturated ketone (X) using 3-benzyl-5-(2-hydroxyethyl)-4-ethylthiazolium chloride as the catalyst gave the 1,4-diketone (XII). Alternatively, addition of vinylmagnesium bromide to ethyl 4-formylbenzoate (XI) followed by oxidation with pyridinium dichromate gave unsaturated ketone (XIII). This was then coupled with quinoxaline aldehyde (VIII) in the presence of a thiazolium salt to furnish diketone (XII).

1 Tai, K.; Yamauchi, T.; Hida, T.; Kikuchi, K.; Nagia, M.; Yoshimura, H.; Tokuhara, N.; Hibi, S.; Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity. J Med Chem 2000, 43, 3, 409.
2 Kikuchi, K.; Tagami, K.; Yoshimura, H.; Hibi, S.; Nagai, M.; Abe, S.; Okita, M.; Hida, T.; Higashi, S.; Tokuhara, N.; Kobayashi, S. (Eisai Co., Ltd.); Heterocyclic carboxylic acid derivs. and drugs containing the same. JP 1997071566; US 5977108; WO 9702244 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(I) 37002 2,2,5,5-tetramethylhexanedioic acid C10H18O4 详情 详情
(II) 37003 diethyl 2,2,5,5-tetramethylhexanedioate C14H26O4 详情 详情
(III) 37004 6-hydroxy-2,2,5,5-tetramethylcyclohexanone C10H18O2 详情 详情
(IV) 37005 3,3,6,6-tetramethyl-1,2-cyclohexanedione C10H16O2 详情 详情
(V) 37006 2,3-diaminopropionic acid 18635-45-5 C3H8N2O2 详情 详情
(VI) 37007 methyl 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinecarboxylate C14H20N2O2 详情 详情
(VII) 37008 (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)methanol C13H20N2O 详情 详情
(VIII) 37009 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinecarbaldehyde C13H18N2O 详情 详情
(IX) 37010 1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)-2-propen-1-ol C15H22N2O 详情 详情
(X) 37011 1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)-2-propen-1-one C15H20N2O 详情 详情
(XI) 10170 methyl 4-formylbenzoate 1571-08-0 C9H8O3 详情 详情
(XII) 37012 methyl 4-[4-oxo-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)butanoyl]benzoate C24H28N2O4 详情 详情
(XIII) 35857 methyl 4-acryloylbenzoate C11H10O3 详情 详情

合成路线17

该中间体在本合成路线中的序号:(IV)

Protection of (R)-glycidol (I) with trityl chloride (II) and TEA in dichloromethane gives the trityl ether (III), which is condensed with vinylmagnesium bromide (IV) in THF to yield the pentenol (V). The alkylation of (V) with allyl bromide (VI) by means of NaH in THF affords the allyl ether (VII), which is oxidized with O3 in methanol/dichloromethane, giving dialdehyde (VIII). Reduction of (VIII) with NaBH4 in ethanol provides diol (IX), which is treated with mesyl chloride and TEA in dichloromethane to afford the fully protected alcohol (X). Cyclization of (X) with 3,4-bis(3-indolyl)-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione (XI) by means of Cs2CO3 in DMF yields the hexacyclic compound (XII), which is N-demethylated by reaction with KOH in refluxing ethanol to give the hexacyclic furan derivative (XIII), which is then treated with hexamethyldisilazane (HMDS) in hot methanol to afford the hexacyclic demethylated pyrrole (XIV). Elimination of the trityl protecting group of (XIV) with HCl in dichloromethane gives the methanol derivative (XV), which is treated with Br2, pyridine and triphenyl phosphite in dichloromethane to yield the bromomethyl derivative (XVI). Finally, this compound is treated with dimethylamine in DMF to provide LY-333531. Alternatively, compound (XV) is treated with methanesulfonic anhydride and pyridine in THF, giving the mesylate (XVII), which is then treated with dimethylamine as before.

1 Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
2 Sorbera, L.A.; Rabasseda, X.; Silvestre, J.S.; Castañer, J.; LY-333531 Mesylate Hydrate. Drugs Fut 2000, 25, 10, 1017-1026.
3 Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
4 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
5 Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
6 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16260 (R)-(+)-Glycidol; (2R)-Oxiranemethanol; (2R)oxiranylmethanol 57044-25-4 C3H6O2 详情 详情
(II) 28630 Triphenylchloromethane; 1-[Chloro(diphenyl)methyl]benzene; Trityl chloride 76-83-5 C19H15Cl 详情 详情
(III) 41006 (2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane C22H20O2 详情 详情
(IV) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(V) 41007 (2S)-1-(trityloxy)-4-penten-2-ol C24H24O2 详情 详情
(VI) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(VII) 41008 1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether C27H28O2 详情 详情
(VIII) 41009 (3S)-3-(2-oxoethoxy)-4-(trityloxy)butanal C25H24O4 详情 详情
(IX) 41010 (3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol C25H28O4 详情 详情
(X) 41011 (3S)-3-[2-[(methylsulfonyl)oxy]ethoxy]-4-(trityloxy)butyl methanesulfonate C27H32O8S2 详情 详情
(XI) 41012 3,4-di(1H-indol-3-yl)-1-methyl-1H-pyrrole-2,5-dione 113963-68-1 C21H15N3O2 详情 详情
(XII) 41016 (18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C46H39N3O4 详情 详情
(XIII) 41017 (18S)-18-[(trityloxy)methyl]-4,17-dioxa-14,21-diazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C45H36N2O5 详情 详情
(XIV) 41014 (18S)-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C45H37N3O4 详情 详情
(XV) 41013 (18S)-18-(hydroxymethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C26H23N3O4 详情 详情
(XVI) 41018 (18S)-18-(bromomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C26H22BrN3O3 详情 详情
(XVII) 41015 [(18S)-3,5-dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl methanesulfonate C27H25N3O6S 详情 详情

合成路线18

该中间体在本合成路线中的序号:(II)

Tetrahydrofuranone (XIII): The Grignard condensation of isobutyraldehyde (I) with vinylmagnesium bromide (II) in THF gives the magnesium alcoholate (III), which is condensed with ethyl malonyl chloride (IV) in the same solvent, yielding the mixed ester (V). Treatment of (V) with Ti(OEt)4 at 190 C affords 6-methyl-4(E)-heptenoic acid methyl ester (VI), which by reaction with (R,R)-(-)-pseudoephedrine (VII), oxalyl chloride and DMF in benzene gives the amide (VIII). The regiocontrolled addition of 4-fluorobenzyl chloride (IX) to the chiral amide (VIII) by means of BuLi and LiCl in THF yields the 2(S)-(4-fluorobenzyl)heptanamide (X), which by reaction with NBS in THF/water/acetic acid at 0 C, followed by reflux for 45 min, affords 5(S)-[1(R)-bromo-2-methylpropyl]-3(R)-(4-fluorobenzyl)tetrahydrofuran-2-one (XI). The reaction of (XI) with NaN3 in DMF gives the corresponding azide (XII), which is reduced with H2 over Pd/C, and the resulting amine is protected with tert-butoxycarbonyl anhydride to obtain the desired tetrahydrofuranone (XIII).

1 Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203.
2 Graul, A.; Castañer, J.; AG-7088. Drugs Fut 2000, 25, 1, 9.
3 Meyer, M.D.; Daanen, J.F.; Ehrlich, P.P.; Ralston, J.W. (Abbott Laboratories Inc.); 3-Phenylpyrrole alpha-1 adrenergic cpds.. WO 9957122 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13226 2-Methylpropanal; Isobutyraldehyde 78-84-2 C4H8O 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 32096 4-Methyl-1-penten-3-ol bromomagnesium salt C6H11BrMgO 详情 详情
(IV) 13188 ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride 36239-09-5 C5H7ClO3 详情 详情
(V) 32097 1-ethyl 3-(1-isopropyl-2-propenyl) malonate C11H18O4 详情 详情
(VI) 32098 methyl (E)-6-methyl-4-heptenoate C9H16O2 详情 详情
(VII) 32104 (1R,2R)-2-amino-1-phenyl-1-propanol C9H13NO 详情 详情
(VIII) 32099 (E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-6-methyl-4-heptenamide C17H25NO2 详情 详情
(IX) 24611 1-(bromomethyl)-4-fluorobenzene 459-46-1 C7H6BrF 详情 详情
(X) 32100 (2S,4E)-2-(4-fluorobenzyl)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-6-methyl-4-heptenamide C24H30FNO2 详情 详情
(XI) 32101 (3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone C15H18BrFO2 详情 详情
(XII) 32102 (3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone C15H18FN3O2 详情 详情
(XIII) 32103 tert-butyl (1S)-1-[(2S,4R)-4-(4-fluorobenzyl)-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate C20H28FNO4 详情 详情

合成路线19

该中间体在本合成路线中的序号:(II)

Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III). Condensation of (III) with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with benzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.

1 Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13226 2-Methylpropanal; Isobutyraldehyde 78-84-2 C4H8O 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 24605 4-methyl-1-penten-3-ol C6H12O 详情 详情
(IV) 16829 Diethyl malonate 105-53-3 C7H12O4 详情 详情
(V) 24607 diethyl 2-[(E)-4-methyl-2-pentenyl]malonate C13H22O4 详情 详情
(VI) 24608 (E)-6-methyl-4-heptenoic acid C8H14O2 详情 详情
(VII) 24609 (1R,2R)-2-(methylamino)-1-phenyl-1-propanol C10H15NO 详情 详情
(VIII) 24610 (E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide C18H27NO2 详情 详情
(IX) 12912 1-(Bromomethyl)benzene; Alpha-bromotoluene 100-39-0 C7H7Br 详情 详情
(X) 24634 (2S,4E)-2-benzyl-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide C25H33NO2 详情 详情
(XI) 24635 (3R,5S)-3-benzyl-5-[(1R)-1-bromo-2-methylpropyl]dihydro-2(3H)-furanone C15H19BrO2 详情 详情
(XII) 24636 (3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-benzyldihydro-2(3H)-furanone C15H19N3O2 详情 详情
(XIII) 24637 tert-butyl (1S)-1-[(2S,4R)-4-benzyl-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate C20H29NO4 详情 详情
(XIV) 24638 (2R,4S,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-methylheptanoic acid C20H31NO5 详情 详情
(XV) 24639 (2R,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-6-methyl-4-oxoheptanoic acid C20H29NO5 详情 详情

合成路线20

该中间体在本合成路线中的序号:(II)

Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III).Transesterification with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with 4-methylbenzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XIII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.

1 Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13226 2-Methylpropanal; Isobutyraldehyde 78-84-2 C4H8O 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 24605 4-methyl-1-penten-3-ol C6H12O 详情 详情
(IV) 16829 Diethyl malonate 105-53-3 C7H12O4 详情 详情
(VI) 24608 (E)-6-methyl-4-heptenoic acid C8H14O2 详情 详情
(VII) 24609 (1R,2R)-2-(methylamino)-1-phenyl-1-propanol C10H15NO 详情 详情
(VIII) 24610 (E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide C18H27NO2 详情 详情
(IX) 24623 1-(bromomethyl)-4-methylbenzene 104-81-4 C8H9Br 详情 详情
(X) 24624 (2S,4E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-2-(4-methylbenzyl)-4-heptenamide C26H35NO2 详情 详情
(XI) 24625 (3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-methylbenzyl)dihydro-2(3H)-furanone C16H21BrO2 详情 详情
(XII) 24626 (3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-methylbenzyl)dihydro-2(3H)-furanone C16H21N3O2 详情 详情
(XIII) 24627 tert-butyl (1S)-2-methyl-1-[(2S,4R)-4-(4-methylbenzyl)-5-oxotetrahydro-2-furanyl]propylcarbamate C21H31NO4 详情 详情
(XIV) 24628 (2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-methyl-2-(4-methylbenzyl)heptanoic acid C21H33NO5 详情 详情
(XV) 24629 (2R,5S)-5-[(tert-butoxycarbonyl)amino]-6-methyl-2-(4-methylbenzyl)-4-oxoheptanoic acid C21H31NO5 详情 详情

合成路线21

该中间体在本合成路线中的序号:(II)

Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III).Transesterification with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with 4-flourobenzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XIII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.

1 Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13226 2-Methylpropanal; Isobutyraldehyde 78-84-2 C4H8O 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 24605 4-methyl-1-penten-3-ol C6H12O 详情 详情
(IV) 16829 Diethyl malonate 105-53-3 C7H12O4 详情 详情
(V) 24607 diethyl 2-[(E)-4-methyl-2-pentenyl]malonate C13H22O4 详情 详情
(VI) 24608 (E)-6-methyl-4-heptenoic acid C8H14O2 详情 详情
(VII) 24609 (1R,2R)-2-(methylamino)-1-phenyl-1-propanol C10H15NO 详情 详情
(VIII) 24610 (E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide C18H27NO2 详情 详情
(IX) 24611 1-(bromomethyl)-4-fluorobenzene 459-46-1 C7H6BrF 详情 详情
(X) 24612 (2S,4E)-2-(4-fluorobenzyl)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide C25H32FNO2 详情 详情
(XI) 24613 (3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone C15H18BrFO2 详情 详情
(XII) 24614 (3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone C15H18FN3O2 详情 详情
(XIII) 24615 tert-butyl (1S)-1-[(2S,4R)-4-(4-fluorobenzyl)-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate C20H28FNO4 详情 详情
(XIV) 24616 (2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-2-(4-fluorobenzyl)-4-hydroxy-6-methylheptanoic acid C20H30FNO5 详情 详情
(XV) 24617 (2R,5S)-5-[(tert-butoxycarbonyl)amino]-2-(4-fluorobenzyl)-6-methyl-4-oxoheptanoic acid C20H28FNO5 详情 详情

合成路线22

该中间体在本合成路线中的序号:(X)

The addition of 2-(trimethylsilyl)ethylmercaptane (I) to 2,4-hexadiyn-1,6-diol (II) catalyzed by KOH in DMF gives the addition product (III), which is oxidized with Dess-Martin periodinane in dichloromethane or oxalyl chloride in DMSO yielding the dialdehyde (IV). The condensation of (IV) with tetrabromomethane by means of triphenylphosphine in dichloromethane affords the tetrabromo derivative (V), which is treated with butyllithium in THF to give the diacetylenic dianion (VI). The reaction of (V) with methyl iodide yields the mono methylated compound (VII), which is condensed with cis-1,2-dichloroethylene (VIII) by means of Pd(PPh3)4/CuI/butylamine in benzene affording the cis-chlorovinyl compound (IX). THe reaction of (IX) with vinylmagnesium bromide (X) catalyzed by Pd(PPh3)4 in benzene gives precursor (XI), which is finally submitted to an oxidative cyclization by means of tetrabutylammonium fluoride/trifluoroacetic acid and iodine.

1 Wang, Y.M.; et al.; Total synthesis and DNA-cleaving properties of thiarubrine C. J Org Chem 1998, 63, 24, 8644.
2 Yang, W.; Koreeda, M.; Chemistry of 1,2-dithiins. Synthesis of the potent antibiotic thiarubrine A. J Am Chem Soc 1994, 116, 10793.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28780 2,4-hexadiyne-1,6-diol 3031-68-3 C6H6O2 详情 详情
(II) 28781 2-(trimethylsilyl)-1-ethanethiol 18143-30-1 C5H14SSi 详情 详情
(III) 28782 (2Z,4Z)-2,5-bis[[2-(trimethylsilyl)ethyl]sulfanyl]-2,4-hexadiene-1,6-diol C16H34O2S2Si2 详情 详情
(IV) 28783 (2Z,4Z)-2,5-bis[[2-(trimethylsilyl)ethyl]sulfanyl]-2,4-hexadienedial C16H30O2S2Si2 详情 详情
(V) 28784 (1Z,3Z)-6,6-dibromo-1-(2,2-dibromovinyl)-4-[[2-(trimethylsilyl)ethyl]sulfanyl]-1,3,5-hexatrienyl 2-(trimethylsilyl)ethyl sulfide C18H30Br4S2Si2 详情 详情
(VI) 28785 3,6-Bis[2-(trimethylsilyl)ethylsulfanyl]octa-3,5-dien-1,7-diyne dilithium salt C18H28Li2S2Si2 详情 详情
(VII) 28786 ((3Z,5Z)-3,6-bis[[2-(trimethylsilyl)ethyl]sulfanyl]-3,5-nonadiene-1,7-diynyl)lithium C19H31LiS2Si2 详情 详情
(VIII) 28793 (Z)-1,2-dichloroethene 156-59-2 C2H2Cl2 详情 详情
(IX) 28792 (1Z,3Z)-1-[(Z)-4-chloro-3-buten-1-ynyl]-4-[[2-(trimethylsilyl)ethyl]sulfanyl]-1,3-heptadien-5-ynyl 2-(trimethylsilyl)ethyl sulfide C21H33ClS2Si2 详情 详情
(X) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XI) 28794 (1Z,3Z)-1-[(3Z)-3,5-hexadien-1-ynyl]-4-[[2-(trimethylsilyl)ethyl]sulfanyl]-1,3-heptadien-5-ynyl 2-(trimethylsilyl)ethyl sulfide C23H36S2Si2 详情 详情

合成路线23

该中间体在本合成路线中的序号:

This compound has been obtained by two related ways: 1) The Grignard reaction of 5,8-dimethylnaphthalene-2-carbaldehyde (I) with vinylmagnesium bromide in ether/THF gives the expected carbinol (II), which is oxidized with MnO2 in dichloromethane yielding the propenone (III). The condensation of (III) with 4-formylbenzoic acid methyl ester (IV) by means of 3-benzyl-5-(hydroxymethyl)-4-methylthiazolium chloride (BHMT) in refluxing ethanol affords the 1,4-butanedione (V), which is cyclized with ammonium acetate in refluxing methanol to give the substituted pyrrole (VI). Finally, the ester group of (V) is hydrolyzed with NaOH in refluxing ethanol/water. 2) 1,4-Butanedione (V) can also be obtained by condensation of 5,8-dimethylnaphthalene-2-carbaldehyde (I) with 4-acryloylbenzoic acid methyl ester (VII) by means of BHMT in hot DMF.

1 Tagami, K.; Yoshimura, H.; Nagai, M.; Hibi, S.; Kikuchi, K.; Sato, T.; Okita, M.; Okamoto, Y.; Nagasaka, Y.; Kobayashi, N.; Hida, T.; Tai, K.; Tokuhara, N.; Kobayashi, S. (Eisai Co., Ltd.); Fused-ring carboxylic acid derivs.. EP 0889032; US 6110959; US 6121309; WO 9734869 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(I) 35852 5,8-dimethyl-2-naphthaldehyde C13H12O 详情 详情
(II) 35853 1-(5,8-dimethyl-2-naphthyl)-2-propen-1-ol C15H16O 详情 详情
(III) 35854 1-(5,8-dimethyl-2-naphthyl)-2-propen-1-one C15H14O 详情 详情
(IV) 10170 methyl 4-formylbenzoate 1571-08-0 C9H8O3 详情 详情
(V) 35855 methyl 4-[4-(5,8-dimethyl-2-naphthyl)-4-oxobutanoyl]benzoate C24H22O4 详情 详情
(VI) 35856 methyl 4-[5-(5,8-dimethyl-2-naphthyl)-1H-pyrrol-2-yl]benzoate C24H21NO2 详情 详情
(VII) 35857 methyl 4-acryloylbenzoate C11H10O3 详情 详情

合成路线24

该中间体在本合成路线中的序号:

The Grignard reaction of 7-fluoro-4-(trifluoromethyl)benzofuran-2-carbaldehyde (I) with vinylmagnesium bromide in ether/THF gives the expected carbinol (II), which is oxidized with MnO2 in dichloromethane yielding the propenone (III). The condensation of (III) with 4-formylbenzoic acid methyl ester (IV) by means of 3-benzyl-5-(hydroxymethyl)-4-methylthiazolium chloride (BHMT) in refluxing ethanol affords the 1,4-butanedione (V), which is cyclized with ammonium acetate in refluxing methanol to give the substituted pyrrole (VI). Finally, the ester group of (V) is hydrolyzed with NaOH in refluxing ethanol/water.

1 Tagami, K.; Yoshimura, H.; Nagai, M.; Hibi, S.; Kikuchi, K.; Sato, T.; Okita, M.; Okamoto, Y.; Nagasaka, Y.; Kobayashi, N.; Hida, T.; Tai, K.; Tokuhara, N.; Kobayashi, S. (Eisai Co., Ltd.); Fused-ring carboxylic acid derivs.. EP 0889032; US 6110959; US 6121309; WO 9734869 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(I) 35847 7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-carbaldehyde C10H4F4O2 详情 详情
(II) 35848 1-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-2-propen-1-ol C12H8F4O2 详情 详情
(III) 35849 1-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-2-propen-1-one C12H6F4O2 详情 详情
(IV) 10170 methyl 4-formylbenzoate 1571-08-0 C9H8O3 详情 详情
(V) 35850 methyl 4-[4-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-4-oxobutanoyl]benzoate C21H14F4O5 详情 详情
(VI) 35851 methyl 4-[5-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-1H-pyrrol-2-yl]benzoate C21H13F4NO3 详情 详情

合成路线25

该中间体在本合成路线中的序号:(XXVI)

The silylation of the acetonide (XVIII) with Tms-Cl and LDA in THF gives dienolate (XIX), which is enantioselectively condensed with acrolein (XX) by means of Carreira's Ti catalyst in ethyl ether to yield the chiral allyl alcohol (XXI). The reaction of (XXI), N,O-dimethylhydroxylamine (XXII) and Me2AlCl affords the amide (XXIII), which is selectively reduced with Me4NBH(OAc)3 in HOAc/acetonitrile to provide the dihydroxyamide (XXIV). The silylation of the OH groups of (XXIV) with Tbdms-Cl and imidazole gives the disilylated compound (XXV), which is submitted to a Grignard reaction with vinylmagnesium bromide (XXVI) in THF to yield the vinyl ketone (XXVII). The Michael addition reaction with Ph2P(O)-Li and simultaneous triflation with (XXVIII) in THF affords the enol triflate (XXIX), which is cyclized by means of Pd(OAc)2, PPh3 and TEA in THF to provide the phosphorane (XXXa-b) as an inseparable mixture of the (Z)- and (E)-isomers. Finally, this mixture is submitted to photochemical isomerization with a medium-pressure UV mercury lamp in the presence of 9-fluorenone, furnishing the target intermediate, the (Z)-isomer (X) with a 95 % yield.

1 Anné, S.; et al.; Enantioselective syntheses of key A-ring precursors of 1alpha,25-dihydroxyvitamin D3 and analogues. Synlett 1999, 9, 1435.
2 Hiyamizu, H.; et al.; A concise enantioselective synthesis of a key A-ring synthon for 1alpha-hydroxyvitamin D3 compounds. Org Lett 2001, 3, 3, 473.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXXa),(X) 42574 [2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethyl](oxo)diphenylphosphorane; 2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethyl(diphenyl)phosphine oxide C33H51O3PSi2 详情 详情
(XXXb) 53658 (E)-2-((3S,5R)-3,5-bis{[tert-butyl(dimethyl)silyl]oxy}-2-methylenecyclohexylidene)ethyl(diphenyl)phosphine oxide; (E)-[2-((3S,5R)-3,5-bis{[tert-butyl(dimethyl)silyl]oxy}-2-methylenecyclohexylidene)ethyl](oxo)diphenylphosphorane n/a C33H51O3PSi2 详情 详情
(XVIII) 13327 2,2,6-Trimethyl-4H-1,3-dioxin-4-one;2,2,6-trimethyl-1,3-dioxin-4-one;2,2,6-trimethyl-m-Dioxin-4-one;3-(1-hydroxy-1-methylethoxy)-d-lactone Crotonicacid 5394-63-8 C7H10O3 详情 详情
(XIX) 53651 [(2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl)oxy](trimethyl)silane; 2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl trimethylsilyl ether n/a C10H18O3Si 详情 详情
(XX) 17668 acrylaldehyde; Acrolein 107-02-8 C3H4O 详情 详情
(XXI) 53652 6-[(2S)-2-hydroxy-3-butenyl]-2,2-dimethyl-4H-1,3-dioxin-4-one n/a C10H14O4 详情 详情
(XXII) 13361 (Methoxyamino)methane; N,O-Dimethylhydroxylamine 1117-97-1 C2H7NO 详情 详情
(XXIII) 53653 (5S)-5-hydroxy-N-methoxy-N-methyl-3-oxo-6-heptenamide n/a C9H15NO4 详情 详情
(XXIV) 53654 (3S,5S)-3,5-dihydroxy-N-methoxy-N-methyl-6-heptenamide n/a C9H17NO4 详情 详情
(XXV) 53655 (3S,5S)-3,5-bis{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N-methyl-6-heptenamide n/a C21H45NO4Si2 详情 详情
(XXVI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XXVII) 53626 (4S)-3,3-diethyl-4-{4-[(4-methyl-1-piperazinyl)carbonyl]phenoxy}-2-azetidinone n/a C19H27N3O3 详情 详情
(XXVIII) 34685 N-(5-chloro-2-pyridinyl)(trifluoro)-N-[(trifluoromethyl)sulfonyl]methanesulfonamide 145100-51-2 C7H3ClF6N2O4S2 详情 详情
(XXIX) 53657 (3S,5S)-3,5-bis{[tert-butyl(dimethyl)silyl]oxy}-1-[(E)-2-(diphenylphosphoryl)ethylidene]-6-heptenyl trifluoromethanesulfonate n/a C34H52F3O6PSSi2 详情 详情

合成路线26

该中间体在本合成路线中的序号:

Addition of vinylmagnesium bromide to diisopropyl ketone (I) produced carbinol (II). Subsequent oxidation of (II) with pyridinium chlorochromate gave unsaturated aldehyde (III), which was further hydrogenated to the saturated aldehyde (IV). Optionally, oxidation with sodium chlorite produced carboxylic acid (V), which was converted to acid chloride (VI) using oxalyl chloride and pyridine.

1 Marquez, V.E.; Bienfait, B.; Lewin, N.E.; Benzaria, S.; Bhattacharyya, D.K.; Lee, J.; Nacro, K.; Han, K.-C.; Kang, J.-H.; Blumberg, P.M.; Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?. J Med Chem 2000, 43, 5, 921.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(I) 39314 2,4-dimethyl-3-pentanone 565-80-0 C7H14O 详情 详情
(II) 39315 3-isopropyl-4-methyl-1-penten-3-ol C9H18O 详情 详情
(III) 39316 3-isopropyl-4-methyl-2-pentenal C9H16O 详情 详情
(IV) 39317 3-isopropyl-4-methylpentanal C9H18O 详情 详情
(V) 39318 3-isopropyl-4-methylpentanoic acid C9H18O2 详情 详情
(VI) 39319 3-isopropyl-4-methylpentanoyl chloride C9H17ClO 详情 详情

合成路线27

该中间体在本合成路线中的序号:(II)

The synthesis of intermediate (VIII) can be achieved by following two different routes: 1) Treatment of 2-bromo-5-methylnitrobenzene (I) with vinyl magnesium bromide (II) in THF yields bromoindole derivative (III), which is then converted into carboxylic acid (IV) by means of BuLi and CO2 in THF. Treatment of (IV) with diphenylphosphoryl azide (DPPA) and Et3N converts the carboxylic group into an amine intermediate which is then treated with hot t-BuOH to afford derivative (V). Formylation of (V) by means of DMF, POCl3 and aqueous NaOH provides aldehyde (VI), which is then treated with hydroxylamine (NH2OH), pyridine and N,N'-carbonyldiimidazole (CDI) and then heated with Et3N to furnish cyano derivative (VII). Finally, removal of the Boc group of (VII) by treatment with TFA in CH2Cl2 gives intermediate (VIII). 2) Alternatively, conversion of 5-methyl-2-nitroaniline (IX) into hydrazone derivative (XI) is achieved by first reaction with NaNO2 in hydrochloric acid media followed by condensation with ethyl 2-methylacetoacetate (X) in EtOH and aqueous KOH. Treatment of (XI) with refluxing H3PO4 in xylene yields indole derivative (XII), which is hydrolyzed by means of aqueous NaOH in THF to afford carboxylic acid (XIII). Decarboxylation of (XIII) with CuCO3 in 1,3-dimethyl-2-imidazolidinone furnishes 4-methyl-7-nitro-1H-indole (XIV), which is then formylated by means of DMF, POCl3 and aqueous NaOH to give aldehyde (XV). Conversion of formyl derivative (XV) into cyano derivative (XVI) is achieved by treatment with hydroxylamine (NH2OH), pyridine and N,N'-carbonyldiimidazole (CDI) followed by heating with Et3N. Finally, hydrogenation of the nitro group of (XVI) over PtO2 affords the target intermediate (VIII).

1 Kamata, J.; Semba, T.; Nara, K.; Ohwa, T.; Hata, N.; Haneda, T.; Funahashi, Y.; Hamaoka, S.; Tsuruoka, A.; Ueda, N.; Wakabayashi, T.; Ozawa, Y.; Yamamoto, Y.; Okabe, T.; Takahashi, K.; Tsukahara, N. (Eisai Co., Ltd.); Sulfonamide-containing indole cpds.. EP 1074542; JP 2000247949; WO 0050395 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 44784 1-bromo-4-methyl-2-nitrobenzene 5326-34-1 C7H6BrNO2 详情 详情
(II) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(III) 44717 7-bromo-4-methyl-1H-indole C9H8BrN 详情 详情
(IV) 44718 4-methyl-1H-indole-7-carboxylic acid C10H9NO2 详情 详情
(V) 44731 tert-butyl 4-methyl-1H-indol-7-ylcarbamate C14H18N2O2 详情 详情
(VI) 44734 tert-butyl 3-formyl-4-methyl-1H-indol-7-ylcarbamate C15H18N2O3 详情 详情
(VII) 44736 tert-butyl 3-cyano-4-methyl-1H-indol-7-ylcarbamate C15H17N3O2 详情 详情
(VIII) 44742 7-amino-4-methyl-1H-indole-3-carbonitrile C10H9N3 详情 详情
(IX) 44745 5-methyl-2-nitrophenylamine; 5-methyl-2-nitroaniline 578-46-1 C7H8N2O2 详情 详情
(X) 10362 ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate 609-14-3 C7H12O3 详情 详情
(XI) 44754 ethyl 2-[(E)-2-(5-methyl-2-nitrophenyl)hydrazono]propanoate C12H15N3O4 详情 详情
(XII) 44755 ethyl 4-methyl-7-nitro-1H-indole-2-carboxylate C12H12N2O4 详情 详情
(XIII) 44756 4-methyl-7-nitro-1H-indole-2-carboxylic acid C10H8N2O4 详情 详情
(XIV) 44757 4-methyl-7-nitro-1H-indole C9H8N2O2 详情 详情
(XV) 44760 4-methyl-7-nitro-1H-indole-3-carbaldehyde C10H8N2O3 详情 详情
(XVI) 44761 4-methyl-7-nitro-1H-indole-3-carbonitrile C10H7N3O2 详情 详情

合成路线28

该中间体在本合成路线中的序号:(A)

From the starting carbaldehyde (I) two different pathways can be followed: 1) A solution of carbaldehyde (I) in ether is treated with the vinyl Grignard reagent (A) in THF and oxidized with activated manganese dioxide to afford enone derivative (II). The derivative is then coupled with methyl 4-formylbenzoate (III) in refluxing ethanol in presence of 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride (B) to yield diketone (IV). 2) Methyl 4-formylbenzoate (III) is treated with vinylmagnesium bromide (A) in THF, and oxidized with pyridinium dichromate to give methyl 4-acryloylbenzoate (V), which is coupled with carbaldehyde (I) by means of 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride (B) and triethylamine in DMF to yield directly diketone (IV). The final step is the cyclization of diketone (IV) to afford the pyrrole-benzoic acid derivative by treatment of the diketone with ammonium acetate in refluxing methanol and hydrolysis with NaOH in refluxing ethanol followed by neutralization with dilute HCl.

1 Tagami, K.; Nagai, M.; Tokuhara, N.; Hida, T.; Yoshimura, H.; Hibi, S.; Yamauchi, T.; Kikuchi, K.; Tai, K.; Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor alpha agonists. Bioorg Med Chem Lett 2000, 10, 7, 623.
2 Tagami, K.; Yoshimura, H.; Nagai, M.; Hibi, S.; Kikuchi, K.; Sato, T.; Okita, M.; Okamoto, Y.; Nagasaka, Y.; Kobayashi, N.; Hida, T.; Tai, K.; Tokuhara, N.; Kobayashi, S. (Eisai Co., Ltd.); Fused-ring carboxylic acid derivs.. EP 0889032; US 6110959; US 6121309; WO 9734869 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(B) 27942 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride 4568-71-2 C13H16ClNOS 详情 详情
(I) 40989 5,8-dimethyl-2H-chromene-3-carbaldehyde C12H12O2 详情 详情
(II) 40990 1-(5,8-dimethyl-2H-chromen-3-yl)-2-propen-1-one C14H14O2 详情 详情
(III) 10170 methyl 4-formylbenzoate 1571-08-0 C9H8O3 详情 详情
(IV) 40991 4-[4-(5,8-dimethyl-2H-chromen-3-yl)-4-oxobutanoyl]benzoic acid C22H20O5 详情 详情
(V) 35857 methyl 4-acryloylbenzoate C11H10O3 详情 详情

合成路线29

该中间体在本合成路线中的序号:(LXXII)

The reaction of the chiral dibenzoyloxy-dihydropyran (LXV) with H2SO4 and HgSO4 gives the unsaturated aldehyde (LXVI), which is condensed with the phosphorane (LXVII) to yield the hepatdienoic ester (LXVIII). The hydrogenation of (LXVIII) with H2 over Pd/C affords the heptanoic ester (LXIX), which is treated with Ts-Cl and pyridine to provide the tosyloxy derivative (LXX). The cyclization of (LXX) by means of K2CO3 gives the chiral epoxide (LXXI), which is condensed with vinylmagnesium bromide (LXXII) to yield 6(S)-hydroxy-8-nonenoic acid methyl ester (LXXIII). The oxidation of the terminal double bond of (LXXIII) with ozone affords the carbaldehyde (LXXIV), which is reduced with NaBH4 to provide 6(S),8-dihydroxyoctanoic acid methyl ester (XLVIII). The reaction of (XLVIII) with Ms-Cl and pyridine gives the dimesylate (XLIX), which is treated with Na2S2 to yield the lipoic acid methyl ester (L), which is hydrolyzed to the target acid with KOH in H2O.

1 Adger, B.; et al.; The synthesis of (R)-(+)-lipoic acid using a monooxygenase-catalysed biotransformation as the key step. Bioorg Med Chem 1997, 5, 2, 253.
2 Adger, B.; et al.; Application of enzymatic Baeyer-Villiger oxidations of 2-substituted cycloalkanones to the total synthesis of (R)-(+)-lipoic acid. J Chem Soc Chem Commun 1995, 15, 1563.
3 McCague, R.; Roberts, S.M.; Adger, B.M. (Celltech Group plc); Process for the production of lipoic acid. WO 9638437 .
4 Villani, F.; Nardi, A.; Salvi, A.; Falabella, G.; Synthesis of R(+)alpha-lipoic acid. WO 0230919 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XLVIII) 57977 methyl (6S)-6,8-dihydroxyoctanoate C9H18O4 详情 详情
(XLIX) 57975 methyl (6S)-6,8-bis[(methylsulfonyl)oxy]octanoate C11H22O8S2 详情 详情
(L) 57976 methyl 5-[(3R)-1,2-dithiolan-3-yl]pentanoate C9H16O2S2 详情 详情
(LXV) 57990 (3R,4S)-4-(benzoyloxy)-3,4-dihydro-2H-pyran-3-yl benzoate C19H16O5 详情 详情
(LXVI) 57991 (1S,2E)-1-(hydroxymethyl)-4-oxo-2-butenyl benzoate C12H12O4 详情 详情
(LXVII) 14689 Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate 2605-67-6 C21H19O2P 详情 详情
(LXVIII) 57992 (1S,2E,4E)-1-(hydroxymethyl)-6-methoxy-6-oxo-2,4-hexadienyl benzoate C15H16O5 详情 详情
(LXIX) 57993 (1S)-1-(hydroxymethyl)-6-methoxy-6-oxohexyl benzoate C15H20O5 详情 详情
(LXX) 57994 (1S)-6-methoxy-1-({[(4-methylphenyl)sulfonyl]oxy}methyl)-6-oxohexyl benzoate C22H26O7S 详情 详情
(LXXI) 57995 methyl 5-[(2S)oxiranyl]pentanoate C8H14O3 详情 详情
(LXXII) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(LXXIII) 57996 methyl (6S)-6-hydroxy-8-nonenoate C10H18O3 详情 详情
(LXXIV) 57997 methyl (6S)-6-hydroxy-8-oxooctanoate C9H16O4 详情 详情

合成路线30

该中间体在本合成路线中的序号:(XVIII)

Synthesis of the thiazole intermediate (XXVI): The Grignard reaction of 2-methyl-3-(2-methylthiazol-4-yl)-2(E)-propenal (XVII) with vinylmagnesium bromide (XVIII) in THF gives the racemic secondary alcohol (XIX), which is submitted to enzymatic optical resolution with Pseudomonas AK lipase and vinyl acetate to yield the desired (S)-secondary alcohol (XX) along with the (R)-acetate, which is easily separated by chromatography. The silylation of (XX) with Tbdms-Cl and imidazole in DMF affords the silyl ether (XXI). The selective hydroboration of the terminal double bond of (XXI) with dichlohexylborane followed by oxidation with H2O2 provides the primary alcohol (XXII), which is oxidized with DMP in dichloromethane to give the corresponding aldehyde (XXIII). The reaction of (XXIII) with the iodomethyl phosphonium salt (XXIV) by means of NaHMDS in THF yields the cis-iodovinyl compound (XXV), which is desilylated with aqueous HF in acetonitrile affording the corresponding alcohol (XXVI). Finally, this alcohol is treated with acetic anhydride, TEA and DMAP to provide the desired thiazole intermediate (XXVII).

1 Panek, J.S.; Zhu, B.; Total synthesis of apothilone A. Org Lett 2000, 2, 17, 2575.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVII) 44456 (E)-2-methyl-3-(2-methyl-1,3-thiazol-4-yl)-2-propenal C8H9NOS 详情 详情
(XVIII) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XIX) 44488 (1E)-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,4-pentadien-3-ol C10H13NOS 详情 详情
(XX) 44489 (1E,3S)-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,4-pentadien-3-ol C10H13NOS 详情 详情
(XXI) 44490 tert-butyl(dimethyl)silyl (1S,2E)-2-methyl-3-(2-methyl-1,3-thiazol-4-yl)-1-vinyl-2-propenyl ether; 4-((1E,3S)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-methyl-1,4-pentadienyl)-2-methyl-1,3-thiazole C16H27NOSSi 详情 详情
(XXII) 40821 (3S,4E)-3-[[tert-butyl(dimethyl)silyl]oxy]-4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-4-penten-1-ol C16H29NO2SSi 详情 详情
(XXIII) 40822 (3S,4E)-3-[[tert-butyl(dimethyl)silyl]oxy]-4-methyl-5-(2-methyl-1,3-thiazol-4-yl)-4-pentenal C16H27NO2SSi 详情 详情
(XXIV) 42718 (iodomethyl)(triphenyl)phosphonium iodide n/a C19H17I2P 详情 详情
(XXV) 44491 4-((1E,3S,5Z)-3-[[tert-butyl(dimethyl)silyl]oxy]-6-iodo-2-methyl-1,5-hexadienyl)-2-methyl-1,3-thiazole; tert-butyl(dimethyl)silyl (1S,3Z)-4-iodo-1-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-3-butenyl ether C17H28INOSSi 详情 详情
(XXVI) 44492 (1E,3S,5Z)-6-iodo-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,5-hexadien-3-ol C11H14INOS 详情 详情
(XXVII) 44493 (1S,3Z)-4-iodo-1-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-3-butenyl acetate C13H16INO2S 详情 详情

合成路线31

该中间体在本合成路线中的序号:(XI)

Nucleophilic substitution of 2,6-dichloro-3-nitrobenzonitrile (I) with methylamine provided the 2-(methylamino) regioisomer (II). The remaining chloride was subsequently displaced with the potassium enolate of ethyl 2-methylacetoacetate (III), yielding adduct (IV). After catalytic hydrogenation of the nitro group of (IV), the resulting amine (V) was condensed with 2,6-dichlorophenyl isothiocyanate (VI) to produce thiourea (VII), which was further cyclized to the benzimidazole (VIII) upon desulfuration with mercuric oxide. Decarbethoxylation and simultaneous cyclization between keto and cyano groups of (VIII) under acidic conditions gave rise to the fused pyridone system (IX). Regioselective oxidation of one methyl group of (IX) using selenium dioxide in hot dioxan furnished aldehyde (X). To this was added the vinyl Grignard reagent (XI), producing the allyl alcohol (XII), which was further esterified to acetate (XIII) with acetic anhydride and triethylamine. Finally, palladium-catalyzed displacement of the acetate group of (XIII) with diethylamine, with concomitant double bond rearrangement, produced the title allylic amine.

1 Goldberg, D.; Cardozo, M.G.; Tschantz, M.A.; Moss, N.; Morwick, T.; Prokopowicz, A.S. III; Snow, R.J.; Patel, U.R.; Wang, X.-J.; Hammach, A.; Takahashi, H. (Boehringer Ingelheim Pharmaceuticals Inc.); Heterocyclic cpds. useful as inhibitors of tyrosine kinases. WO 0125238 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52340 2,6-Dichloro-3-nitrobenzonitrile 5866-98-8 C7H2Cl2N2O2 详情 详情
(II) 52341 6-chloro-2-(methylamino)-3-nitrobenzonitrile C8H6ClN3O2 详情 详情
(III) 10362 ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate 609-14-3 C7H12O3 详情 详情
(IV) 52342 ethyl 2-[2-cyano-3-(methylamino)-4-nitrophenyl]-2-methyl-3-oxobutanoate C15H17N3O5 详情 详情
(V) 52343 ethyl 2-[4-amino-2-cyano-3-(methylamino)phenyl]-2-methyl-3-oxobutanoate C15H19N3O3 详情 详情
(VI) 52344 2,6-Dichlorophenyl isothiocyanate 6590-95-0 C7H3Cl2NS 详情 详情
(VII) 52345 ethyl 2-[2-cyano-4-({[(2,6-dichlorophenyl)amino]carbothioyl}amino)-3-(methylamino)phenyl]-2-methyl-3-oxobutanoate C22H22Cl2N4O3S 详情 详情
(VIII) 52346 ethyl 2-{7-cyano-2-[(2,6-dichlorophenyl)amino]-1-methyl-1H-benzimidazol-6-yl}-2-methyl-3-oxobutanoate C22H20Cl2N4O3 详情 详情
(IX) 52347 2-[(2,6-dichlorophenyl)amino]-1,6,7-trimethyl-1,8-dihydro-9H-imidazo[4,5-h]isoquinolin-9-one C19H16Cl2N4O 详情 详情
(X) 52348 2-[(2,6-dichlorophenyl)amino]-1,6-dimethyl-9-oxo-8,9-dihydro-1H-imidazo[4,5-h]isoquinoline-7-carbaldehyde C19H14Cl2N4O2 详情 详情
(XI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XII) 52349 2-[(2,6-dichlorophenyl)amino]-7-(1-hydroxy-2-propenyl)-1,6-dimethyl-1,8-dihydro-9H-imidazo[4,5-h]isoquinolin-9-one C21H18Cl2N4O2 详情 详情
(XIII) 52350 1-{2-[(2,6-dichlorophenyl)amino]-1,6-dimethyl-9-oxo-8,9-dihydro-1H-imidazo[4,5-h]isoquinolin-7-yl}-2-propenyl acetate C23H20Cl2N4O3 详情 详情

合成路线32

该中间体在本合成路线中的序号:(XI)

Nucleophilic substitution of 2,6-dichloro-3-nitrobenzonitrile (I) with methylamine provided the 2-(methylamino) regioisomer (II). The remaining chloride was subsequently displaced with the potassium enolate of ethyl 2-methylacetoacetate (III), yielding adduct (IV). After catalytic hydrogenation of the nitro group of (IV), the resulting amine (V) was condensed with 2,6-dichlorophenyl isothiocyanate (VI) to produce thiourea (VII), which was further cyclized to the benzimidazole (VIII) upon desulfuration with mercuric oxide. Decarbethoxylation and simultaneous cyclization between keto and cyano groups of (VIII) under acidic conditions gave rise to the fused pyridone system (IX). Regioselective oxidation of one methyl group of (IX) using selenium dioxide in hot dioxan furnished aldehyde (X). To this was added the vinyl Grignard reagent (XI), producing the allyl alcohol (XII), which was further esterified to acetate (XIII) with acetic anhydride and triethylamine. Finally, palladium-catalyzed displacement of the acetate group of (XIII) with dimethylamine, with concomitant double bond rearrangement, produced the title allylic amine.

1 Goldberg, D.; Cardozo, M.G.; Tschantz, M.A.; Moss, N.; Morwick, T.; Prokopowicz, A.S. III; Snow, R.J.; Patel, U.R.; Wang, X.-J.; Hammach, A.; Takahashi, H. (Boehringer Ingelheim Pharmaceuticals Inc.); Heterocyclic cpds. useful as inhibitors of tyrosine kinases. WO 0125238 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52340 2,6-Dichloro-3-nitrobenzonitrile 5866-98-8 C7H2Cl2N2O2 详情 详情
(II) 52341 6-chloro-2-(methylamino)-3-nitrobenzonitrile C8H6ClN3O2 详情 详情
(III) 10362 ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate 609-14-3 C7H12O3 详情 详情
(IV) 52342 ethyl 2-[2-cyano-3-(methylamino)-4-nitrophenyl]-2-methyl-3-oxobutanoate C15H17N3O5 详情 详情
(V) 52343 ethyl 2-[4-amino-2-cyano-3-(methylamino)phenyl]-2-methyl-3-oxobutanoate C15H19N3O3 详情 详情
(VI) 52344 2,6-Dichlorophenyl isothiocyanate 6590-95-0 C7H3Cl2NS 详情 详情
(VII) 52345 ethyl 2-[2-cyano-4-({[(2,6-dichlorophenyl)amino]carbothioyl}amino)-3-(methylamino)phenyl]-2-methyl-3-oxobutanoate C22H22Cl2N4O3S 详情 详情
(VIII) 52346 ethyl 2-{7-cyano-2-[(2,6-dichlorophenyl)amino]-1-methyl-1H-benzimidazol-6-yl}-2-methyl-3-oxobutanoate C22H20Cl2N4O3 详情 详情
(IX) 52347 2-[(2,6-dichlorophenyl)amino]-1,6,7-trimethyl-1,8-dihydro-9H-imidazo[4,5-h]isoquinolin-9-one C19H16Cl2N4O 详情 详情
(X) 52348 2-[(2,6-dichlorophenyl)amino]-1,6-dimethyl-9-oxo-8,9-dihydro-1H-imidazo[4,5-h]isoquinoline-7-carbaldehyde C19H14Cl2N4O2 详情 详情
(XI) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(XII) 52349 2-[(2,6-dichlorophenyl)amino]-7-(1-hydroxy-2-propenyl)-1,6-dimethyl-1,8-dihydro-9H-imidazo[4,5-h]isoquinolin-9-one C21H18Cl2N4O2 详情 详情
(XIII) 52350 1-{2-[(2,6-dichlorophenyl)amino]-1,6-dimethyl-9-oxo-8,9-dihydro-1H-imidazo[4,5-h]isoquinolin-7-yl}-2-propenyl acetate C23H20Cl2N4O3 详情 详情

合成路线33

该中间体在本合成路线中的序号: (V)

 

1 Trost BM, Andersen NG. 2002. Utilization of molybdenum-and palladium-catalyzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quatemary stereogenic centers; a concise synthesis of tipranavir. J Am Chem Soc, 124 (48): 14320~14321
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 66865 methyl 3-(3-nitrophenyl)pent-4-enoate   C12H13NO4 详情 详情
(V) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(VII) 66867 1-propyl-1-vinylcyclopropane   C8H14 详情 详情
(IX) 66869 (E)-2-((4-methoxybenzyl)oxy)-2-styrylpentan-1-ol   C21H26O3 详情 详情
(XII) 66872 (5S)-methyl 5-((4-methoxybenzyl)oxy)-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate   C34H39NO7 详情 详情
(XIII) 66873 (5S)-methyl 5-hydroxy-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate   C26H31NO6 详情 详情
(XIV) 66874 (S)-4-hydroxy-3-((R)-1-(3-nitrophenyl)allyl)-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one   C25H27NO5 详情 详情
(XV) 21168 (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H29NO5 详情 详情
(I) 66862 1-(3-nitrophenyl)prop-2-en-1-ol   C9H9NO3 详情 详情
(II) 66863 tert-butyl (1-(3-nitrophenyl)allyl) carbonate   C14H17NO5 详情 详情
(III) 66864 dimethyl 2-(1-(3-nitrophenyl)allyl)malonate   C14H15NO6 详情 详情
(VI) 66866 1-chloropentan-2-one   C5H9ClO 详情 详情
(VIII) 66868 2-((4-methoxybenzyl)oxy)-2-vinylpentan-1-ol   C15H22O3 详情 详情
(X) 66870 2-((4-methoxybenzyl)oxy)-2-phenethylpentan-1-ol   C21H28O3 详情 详情
(XI) 66871 1-methoxy-4-(((3-phenethylhex-1-en-3-yl)oxy)methyl)benzene   C22H28O2 详情 详情
(XVI) 66879 2-((4-methoxybenzyl)oxy)-2-phenethylpentanal   C21H26O3 详情 详情
Extended Information